stocksGoogle News
Stock markets snap three-day rally on rate hike fears; Sensex drops 318 points - The Hindu
Stock markets snap three-day rally on rate hike fears; Sensex drops 318 points The Hindu
GN3 hours ago
Read More//
S3V Vascular Technologies Limited · Healthcare & Pharmaceuticals · S3V Vascular Technologies Unlisted / Pre-IPO Share Price
As of 14 Nov 2026, the S3V Vascular Technologies Limited unlisted share price is ₹545 per share. Implied valuation: ₹1,057 Cr. S3V Vascular Technologies Limited is an unlisted / pre-IPO company — not listed on NSE or BSE. Minimum investment: ₹50,000. ISIN: INE0HGT01012.
Key figures for S3V Vascular Technologies Limited
S3V Vascular Technologies Limited — founded in 2011, headquartered in Mysore, Karnataka. Focuses on development and manufacturing of advanced medical devices for cardiovascular and critical-care applications. S3V became the first company in the world to receive a manufacturing license for an expandable titanium-based Intervertebral Body Fusion Device / Expandable Spinal Cage — the first successful spinal implant was done in Pune, and S3V remains the only manufacturer of this expandable cage globally. S3V follows a fully integrated model combining in-house R&D, proprietary technology development, and regulated manufacturing facilities. It serves both Indian and global markets through: Cardiovascular and neurovascular diseases are rising rapidly — India represents a massive demand base for minimally invasive medical devices. The neuro-intervention market alone is a $2-billion segment, currently dominated by imported products. S3V targets this gap through indigenous manufacturing, regulatory compliance (ISO-13485, CE approvals), and reduction of import costs — increasing access in India and emerging markets.
| Particulars | FY22 | FY23 | FY24 | FY25 LATEST |
|---|---|---|---|---|
| Revenue | 21 | 19 | 15 | 13.5▼10% |
| EBITDA | 5.8 | 3.7 | 2.5 | -0.57▼123% |
| OPM (%) | 27.62% | 19.47% | 16.67% | -4.22%▼125% |
| PBT | 2.8 | 0.65 | -3.06 | 0.15▲105% |
| PAT | 2.7 | 0.56 | -3.19 | 0.06▲102% |
| EPS (₹) | ₹2.08 | ₹0.42 | ₹-1.66 | ₹0.03▲102% |
Figures in ₹ Crore unless marked ₹ (per share) or %. Source: company filings via unlistedzone.
S3V Vascular Technologies shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
New to unlisted shares? Read how buying unlisted shares works with Safal Capital, compare prices on the unlisted shares screener or see today's unlisted share price list.
No. S3V Vascular Technologies is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “S3V Vascular Technologies share price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
S3V Vascular Technologies has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for S3V Vascular Technologies is INE0HGT01012. Contact our desk for the latest status and a live quote before you invest.
As of 14 Nov 2026, the S3V Vascular Technologies unlisted (pre-IPO) share price is ₹545 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
At the unlisted share price of ₹545, S3V Vascular Technologies's implied market valuation is about ₹1,057 Cr (share price × total shares outstanding). This is an indicative, market-implied figure that moves with the unlisted price — not an official company valuation.
You buy S3V Vascular Technologies unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. S3V Vascular Technologies is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
S3V Vascular Technologies has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on S3V Vascular Technologies.
The ISIN for S3V Vascular Technologies unlisted shares is INE0HGT01012. You will need this ISIN when the shares are credited to your demat account.
S3V Vascular Technologies unlisted shares have a face value of ₹10 and a typical minimum lot of 500 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The S3V Vascular Technologies price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like S3V Vascular Technologies can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess S3V Vascular Technologies.
Safal Capital tracks S3V Vascular Technologies Limited for pricing updates, liquidity context, and investor suitability.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Unlisted shares like S3V Vascular Technologies are high-growth but illiquid. Balance them with these — all with the same SEBI-registered team.
Latest source-linked updates that may be relevant to this company.
Stock markets snap three-day rally on rate hike fears; Sensex drops 318 points The Hindu
Share Market News: Nifty 50 Outlook & Prediction Liquide Blog
Razorpay Gets Sebi Clearance For IPO, Targets 2027 Market Debut BW Businessworld